In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
Metastatic tumor in the lung, with different colors used to represent the cell nuclei, the blood vessels, and the P-selectin protein.
In the Lab
Hacking Metastasis: Nanotechnology Researchers Find New Way to Target Tumors

A protein in blood vessels that plays a role in cancer metastasis is a promising target for delivering cancer drugs to tumors using nanoparticles.
A doctor speaks with a patient who has advanced prostate cancer about inherited mutations.
In the Clinic
Study Suggests Men with Metastatic Prostate Cancer Should Be Tested for Inherited Mutations

Learn why a new finding suggests that men with advanced prostate cancer should be screened for gene mutations.
Man at airport
Feature
What to Know about Traveling with Cancer

Traveling with cancer can be done, even if you’re in active treatment. Plan ahead so that you can fully enjoy your vacation.
Lymphoblastic leukemia survivor speaking at Fabulous and Fighting event for cancer patients.
Survivorship
Guilt: A Lasting Side Effect for Cancer Survivors

Feelings of guilt are common after surviving cancer, but MSK offers many support services that can help patients feel better.
Memorial Sloan Kettering ovarian cancer patient Vilma Rosario and her partner, Michele Freeman, pose at the Statue of Liberty.
Feature
Ovarian Cancer Didn’t Cuff This Cop

Meet a former NYPD officer who is battling a vicious enemy - ovarian cancer - with support from her new wife.
Palliative care nurse practitioner Tammy Son
In the Clinic
At MSK, Nurse Researchers Are Studying Ways to Improve Cancer Care

Learn how nurses at MSK also engage in cancer research projects designed to help improve patients’ treatment, symptoms, or experience.
MSK Pediatric Prom
Feature
Celebrating School’s End at MSK with Pediatric Prom and High School Convocation

Discover how current and former Memorial Sloan Kettering pediatric cancer patients closed out the end of the school year.
MSK gynecologic oncologist Carol Brown
Q&A
Q & A with Carol Brown: Clinical Trials and Cancer Disparities

MSK physician Carol Brown spoke about cancer disparities at The US State of Women Summit organized by the White House. Learn how she and MSK are leading the way in addressing this issue.
MSK physician Aimee Crago consults with two colleagues.
In the Clinic
New Targeted Drug Therapy for Advanced Sarcoma Extends Survival by Nearly a Year

Learn more about olaratumab, a promising drug that has been shown to extend survival for people with advanced soft tissue sarcoma — particularly leiomyosarcoma — by nearly a year in a phase II clinical trial.
Memorial Sloan Kettering Study Shows Targeted Therapy for Advanced Sarcoma Extends Survival by Nearly a Year

A new drug is being shown to extend the lives of patients with advanced soft tissue sarcoma by almost a year. The results of a multicenter phase II trial evaluating the efficacy and safety of olaratumab in combination with doxorubicin chemotherapy was published in The Lancet on June 9. William Tap, MD, Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), served as corresponding author on this study, which met its primary endpoint of progression-free survival and showed a statistically significant improvement in overall survival. To arrange an interview with Dr. Tap, please email [email protected].